Korea Health Industry Development Institute announced on April 17 that it is hosting the Bio Korea International Convention from April 17-19.
Session coordinators, including Bridge Bio CEO Lee Jung-kyu and Korea University and Hospital professor Lee Sang-hun, introduced topics that will be discussed during the forum.
Lee especially emphasized the forum’s main theme, which is open innovation in the local bio industry.
“Korean companies like Hanmi and Yuhan have developed new drugs and signed good license deals,” he said. “Now is a good time for our industry to focus more on open innovation for further expansion in global markets.
Lee also added that it is also important for bio and pharma companies to acquire foreign companies like Chinese companies.
Furthermore, participants also talked about the future of Korea’s bio industry.
Bio business consulting firm Hyun& Partners founder Park Jae-chul talked about cell therapies. “Ultimately, this tech will make it possible to produce a customized drug for different patients,” Park said.
Korea University professor Lee Sang-hun also talked about how his university has formed a cloud system that contains data from 3,700 different hospitals with IT firms Naver and Samsung SDS.
By Song Seung-hyun (firstname.lastname@example.org)